Advertisement

Donor and Recipient Selection

  • Stuart M. Flechner

Abstract

Kidney transplantation has evolved from an experiment to the preferred form of replacement therapy for the majority of patients suffering from end-stage renal disease (ESRD) (1,2). During the 1980s, the number of transplants performed in the United States increased yearly, but has now plateaued at about 10,000 cases per year due primarily to the current ceiling of available cadaveric organs (3,4). This fact, coupled with an ever-increasing number of new patients maintained on dialysis, has made transplantation available to no more than 5% of the current ESRD population. As reported to the Health Care Financing Administration by January 1, 1992, there were 180,000 patients receiving dialysis therapy of all types in the United States (5). In the previous year, 10,052 received kidney transplants—7667 from cadaveric donors and 2385 from living donors—which left an additional 18,314 patients on active waiting lists for a donor kidney (6). It has also been estimated that an additional 10,000–20,000 ESRD patients would elect to receive a kidney transplant if they received further education and information and if the available pool of cadaveric kidneys were expanded.

Keywords

Graft Survival Brain Death Renal Transplant Recipient Transplant Proc ESRD Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Evans RW: The benefits of transplantation. Survival and quality of life. In: RW Evans, DL Manninen, F Dong, eds, The National Cooperative Transplantation Study. Battelle Research Center, Seattle, 1991.Google Scholar
  2. 2.
    Evans RW: Need, demand, and supply in kidney transplantation. A review of data and examination of the issues, and projections through the year 2000. Semin Nephrol 12: 234255, 1992.Google Scholar
  3. 3.
    Spital A: The shortage of organs for transplantation: Where do we go from here? N Engl J Med 325: 1243–1246, 1991.PubMedCrossRefGoogle Scholar
  4. 4.
    Evans RW, Orians CE, Ascher NL: The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. DAMA 267: 239–246, 1992.CrossRefGoogle Scholar
  5. 5.
    The United States Renal Data Systems: 1993 Annual Report. Prevalence of Reported ESRD Therapy. The National Institutes of Health, Bethesda, MD, March 1993.Google Scholar
  6. 6.
    The United States Renal Data Systems: 1993 Annual Report. The Kidney Transplant Process. The National Institutes of Health, Bethesda, MD, March 1993.Google Scholar
  7. 7.
    Cecka JM, Terasaki PI: The UNOS Scientific Registry. In: Clinical Transplants 1993. The University of California Press, Los Angeles, CA, pp 1–18, 1994.Google Scholar
  8. 8.
    Terasaki PI, Toyotome A, Mickey R, Iwaki Y, Cecka JM: Patient graft and functional survival rates. In: Clinical Kidney Transplants. University of California Press, Los Angeles, CA, pp 141–257, 1988.Google Scholar
  9. 9.
    Krakauer H, Grauman JS, McMullen MR, Creede CC: The recent U.S. experience in the treatment of ESRD by dialysis and transplantation. N Engl J Med 308: 1558–1562, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Najarian JS, Matas AJ: The present and future of kidney transplantation. Transplant Proc 23: 2075–2082, 1991.PubMedGoogle Scholar
  11. 11.
    Christiansen AJ, Holman JM, Turner CW: Quality of life in ESRD: influence of renal transplantation. Clin Transplant 3: 46–53, 1989.Google Scholar
  12. 12.
    Flechner SM, Novick AC, Braun WE, et al.: Functional capacity and rehabilitation of recipients with a functioning renal allograft 10 years or more. Transplantation 35: 572–576, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Simmons RG, Abress L, Andersen C. Rehabilitation after kidney transplantation. In: G Cerilli, ed, Organ Transplantation and Replacement. JB Lippincott, New York, pp 481–489, 1988.Google Scholar
  14. 14.
    Devins GM, Binik YM, Hutchinson TA: The emotional impact of ESRD: importance of patient’s perceptions of intrusiveness and control. Int J Psychiatry Med 13: 327–335, 1984.CrossRefGoogle Scholar
  15. 15.
    Port FK: Worldwide demographics and future trends in ESRD. Kidney Int 43 (Suppl): 51–57, 1993.Google Scholar
  16. 16.
    Hart LG, Evans RW: The functional status of ESRD patients as measured by the sickness impact profile. J Chronic Dis 40 (Suppl 1): 117–130, 1987.CrossRefGoogle Scholar
  17. 17.
    Armenti VT, Ahlswede KM, Darrel B, et al.: National transplantation pregnancy registry: analysis at pregnancy outcome. Transplant Proc 25: 1036–1037, 1993.PubMedGoogle Scholar
  18. 18.
    Davison JM: Dialysis, transplantation and pregnancy. Am J Kidney Dis 17: 127–132, 1991.PubMedGoogle Scholar
  19. 19.
    Fox E, Peace K, Neale TJ, et al.: Quality of life for patients with ESRD. Renal Failure 13: 31–35, 1991.PubMedCrossRefGoogle Scholar
  20. 20.
    Vollmer WM, Wahl RW, Blagg CR: Survival with dialysis and transplantation in patients with ESRD. N Engl J Med 308: 1553–1557, 1983.PubMedCrossRefGoogle Scholar
  21. 21.
    Burton PR, Walls J: Selection adjusted comparison of life expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis, and renal transplantation. Lancet 1: 1115–1119, 1987.PubMedCrossRefGoogle Scholar
  22. 22.
    Hutchinson TA, Thomas DC, MacFibbon B: Predicting survival in adults with ESRD: an age equivalency index. Ann Intern Med 96: 417–424, 1982.PubMedCrossRefGoogle Scholar
  23. 23.
    Garcia-Garcia G, Deddens JA, D’Achiardi-Rey R, et al.: Results of treatment in patients with ESRD: a multivariate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis 5: 10–18, 1985.PubMedGoogle Scholar
  24. 24.
    Minetti L, Civati G, Brando B, et al.: A comparison between maintenance hemodialysis and transplantation in the treatment of ESRD. Transplant Proc 17 (Suppl 2): 28–31, 1985.Google Scholar
  25. 25.
    Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE: Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 26: 44–51, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Weller JM, Port- FK, Swartz RD, Ferguson CW, Williams GW: Analysis of survival of ESRD patients. Kidney Int 21: 78–83, 1982.PubMedCrossRefGoogle Scholar
  27. 27.
    Port FK, Wolfe RA, Mauger EA, Berling D, Jiang K: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270: 1339–1343, 1993.PubMedCrossRefGoogle Scholar
  28. 28.
    Flom LS, Riesman EM, Donovan JM, et al.: Favorable experience with preemptive renal transplantation in children. Pediatr Nephol 6: 258–261, 1992.CrossRefGoogle Scholar
  29. 29.
    Migliori RJ, Simmons R, Payne WD, et al.: Renal transplantation done safely without prior chronic dialysis therapy. Transplantation 43: 51–55, 1987.PubMedCrossRefGoogle Scholar
  30. 30.
    Engelhardt HT: Allocating scarce medical resources and the availability of organ transplantation. N Engl J Med 311: 6671, 1984.CrossRefGoogle Scholar
  31. 31.
    Cohen B: Organ donor shortage: European situation and possible solutions. Scand J Urol Nephrol 92: 77–80, 1985.Google Scholar
  32. 32.
    Organ Donors in the U.K.-getting the numbers right (editorial). Lancet 335: 80–82, 1990.CrossRefGoogle Scholar
  33. 33.
    Ubel PA, Arnold RM, Caplan A: Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA 270: 2469 2474, 1993.Google Scholar
  34. 34.
    Fryer JP, Matas AJ: How to identify the best candidates for kidney transplantation. J Crit Illness 9: 362–374, 1994.Google Scholar
  35. 35.
    Cantarovich D, Baranger T, Tirouvanzian R, et al.: One hundred and five kidney transplants with cyclosporine in recipients over 60 years of age. Transplant Proc 25: 1323–1324, 1993.PubMedGoogle Scholar
  36. 36.
    Pirsch J, Stratta RJ, Armbrust MJ, et al.: Cadaveric renal transplantation with cyclosporine in patients more than 60 years of age. Transplantation 47: 259–263, 1989.PubMedCrossRefGoogle Scholar
  37. 37.
    Schulak JA, Mayes JT, Johnston K, et al.: Kidney transplantation in patients age 60 years and older. Surgery 108: 726733, 1991.Google Scholar
  38. 38.
    Vivas CA, Hickey DP, Jordan M, et al.: Renal transplantation in patients 65 years or older. J Urol 147: 990–993, 1992.PubMedGoogle Scholar
  39. 39.
    Mailloux LV, Bellucci AG, Wilkes BM, et al.: Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 18: 326–335, 1991.PubMedGoogle Scholar
  40. 40.
    Horina JH, Holzer H, Reisinger EC, et al.: Elderly patients and chronic hemodialysis. Lancet 339: 183–184, 1992.PubMedCrossRefGoogle Scholar
  41. 41.
    Derfter K, Kletler K, Balcke P, et al.: Predictive value of thallium-201 dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 36: 192–202, 1990.Google Scholar
  42. 42.
    Helderman JH: The role of cardiovascular disease in renal transplantation. In: M Garovoy, Guttmann, eds, Renal Transplantation. Churchill-Livingstone, New York, pp 209232, 1986.Google Scholar
  43. 43.
    DeMeyer M, Wyns W, Dion R, et al.: Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 36: 147–151, 1991.Google Scholar
  44. 44.
    Moel DI, Butt K: Renal transplantation in children less than two years of age. J Pediatr 99: 535–539, 1981.PubMedCrossRefGoogle Scholar
  45. 45.
    Fletcher JC: Moral problems and ethical issues in the management of children with chronic renal failure. In: Proceedings of Conference on Chronic Renal Disease: Unique Problems of the Child with Renal Failure. National Institutes of Health, Bethesda, MD, March 5–6, 1981.Google Scholar
  46. 46.
    McEnery PT, Stablein DM, Arbus G, et al.: Renal transplantation in children. Report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 326: 1727–1732, 1992.PubMedCrossRefGoogle Scholar
  47. 47.
    Conley SB, Flechner SM, Rose G, et al.: The use of cyclosporine in pediatric renal transplant recipients. J Pediatr 106: 45–49, 1985.PubMedCrossRefGoogle Scholar
  48. 48.
    Najarian JS, Frey DJ, Matas AJ, et al.: Renal transplantation in infants. Ann Surg 212: 353–367, 1990.PubMedCrossRefGoogle Scholar
  49. 49.
    Fine R: Peritoneal dialysis in children. J Pediatr 100: 1–4, 1982.PubMedCrossRefGoogle Scholar
  50. 50.
    Penn I: Leukemias and lymphomas associated with the use of cytotoxic and immunosuppressive drugs. Cancer Res 69: 7–17, 1979.Google Scholar
  51. 51.
    Penn I: Renal transplantation in patients with pre-existing malignancies. Transplant Proc 15: 1079–1082, 1983.Google Scholar
  52. 52.
    Penn I: The effect of immunosuppression on pre-existing cancers. Transplantation 55: 742–747, 1993.PubMedCrossRefGoogle Scholar
  53. 53.
    Rubin RH, Tolkhoff-Rubin NE: The impact of infection on the outcome of transplantation. Transplant Proc 23: 2068 2074, 1991.Google Scholar
  54. 54.
    Rubin RH: Infectious disease complications of renal transplantation. Kidney Int 44: 221–236, 1993.PubMedCrossRefGoogle Scholar
  55. 55.
    Rubin RH, Tolkhoff-Rubin NE: Antimicrobial strategies in the case of organ transplant recipients. Antimicrob Agents Chemother 37: 619–624, 1993.PubMedCrossRefGoogle Scholar
  56. 56.
    Reyna J, Richardson J, Mattox D, et al.: Head and neck infection after renal transplantation. JAMA 247: 3337–3339, 1982.PubMedCrossRefGoogle Scholar
  57. 57.
    Coutts I, Jegarajah S, Stark TE: Tuberculosis in renal transplant patients. Br J Dis Chest 73: 141–145, 1979.PubMedCrossRefGoogle Scholar
  58. 58.
    Andrew OT, Schoenfield P, Hopewell PC, Humphreys M: Tuberculosis in patients with ESRD. Am J Med 68: 59–65, 1980.PubMedCrossRefGoogle Scholar
  59. 59.
    Flechner SM, Gow JG: Role of nephrectomy in treatment of the nonfunctioning unilateral tuberculous kidney. J Urol 123: 822–825, 1980.PubMedGoogle Scholar
  60. 60.
    Erice A, Phame FS, Heussner RC, et al.: HIV infection in organ transplant recipients. Rev Infect Dis 13: 537–540, 1991.PubMedCrossRefGoogle Scholar
  61. 61.
    Keay S, Behrens MT, Klassen D, et al.: Impact of asymptomatic HIV infection on renal allograft recipients. Transplant Proc 25: 1478–1480, 1993.PubMedGoogle Scholar
  62. 62.
    Parfrey PS, Forbes R, Hutchinson TA, et al.: The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 37: 461–465, 1984.PubMedCrossRefGoogle Scholar
  63. 63.
    Parfrey PS, Forbes R, Hutchinson TA, et al.: The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 38: 610–615, 1985.CrossRefGoogle Scholar
  64. 64.
    Parfrey PS, Farge O, Forbes R, et al.: Chronic hepatitis in ESRD: comparison of HBsAg positive and HBsAg negative patients. Kidney Int 28: 959–965, 1985.PubMedCrossRefGoogle Scholar
  65. 65.
    Rao KV, Dasiske BL, Anderson WR: Variability in the morphology spectrum and clinical outcome of chronic liver disease in hepatitis B positive and B negative renal transplant recipients. Transplantation 51: 391–394, 1991.PubMedGoogle Scholar
  66. 66.
    Katkow WN, Rubin RH: Liver disease in the organ transplant recipient: etiology, clinical impact, and clinical management. Transplant Rev 5: 200–208, 1991.CrossRefGoogle Scholar
  67. 67.
    Pirson Y, Alexandre G, Ypersele C: Long-term effect of HB antigenemia on patient survival after renal transplantation. N Engl J Med 296: 194–198, 1977.PubMedCrossRefGoogle Scholar
  68. 68.
    Weir MR, Kirkman RL, Strom TB, Tilney N: Liver disease in recipients of long functioning renal allografts. Kidney Int 28: 839–845, 1985.PubMedCrossRefGoogle Scholar
  69. 69.
    Harnett JD, Zeldis JB, Parfrey PS, et al.: Hepatitis B disease in dialysis and transplant patients. Transplantation 44: 369373, 1987.Google Scholar
  70. 70.
    Rao KV, Anderson RC: Long term results and complications in renal transplant recipients. Observations in the second decade. Transplantation 45: 45–52, 1988.PubMedCrossRefGoogle Scholar
  71. 71.
    Pol S, Debure A, Degott C, et al.: Chronic hepatitis in kidney allograft recipients. Lancet 335: 878–880, 1990.PubMedCrossRefGoogle Scholar
  72. 72.
    Weller IV, Bassendine M, Murray A, et al.: Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut 23: 650–6656, 1982.PubMedCrossRefGoogle Scholar
  73. 73.
    Huang CC, Lai MK, Fong MT: Hepatitis B liver disease in cyclosporine treated renal allograft recipients. Transplantation 49: 540–544, 1990.PubMedCrossRefGoogle Scholar
  74. 74.
    Schweitzer EJ, Bartlett S, Keay S, et al.: Impact of hepatitis B or C infection on the practice of kidney transplantation in the U.S. Transplant Proc 25: 1456–1457, 1993.PubMedGoogle Scholar
  75. 75.
    Roth D, Fernandez JA, Burke GW, et al.: Detection of antibody to hepatitis C virus in renal transplant recipients. Transplantation 51: 396–401, 1991.PubMedCrossRefGoogle Scholar
  76. 76.
    Huang CC, Liaw YF, Lai MM, et al.: The clinical outcome of hepatitis C virus antibody positive renal allograft recipients. Transplantation 53: 763–769, 1992.PubMedCrossRefGoogle Scholar
  77. 77.
    Orloff SL, Tomlanovitch S, Stock PG, et al.: Long-term outcome of kidney transplant patients with hepatitis C infection. Proc Am Soc Transplanty Surgeons 19: 181, 1993.Google Scholar
  78. 78.
    Tesi RJ, Waller K, Morgan CJ, et al.: Transmission of hepatitis C by kidney transplantation-the risks. Transplantation 57: 826–831, 1994.PubMedCrossRefGoogle Scholar
  79. 79.
    Dunn J, Golden D, Van Baren CT, et al.: Causes of graft loss beyond two years in the cyclosporine era. Transplantation 49: 349–353, 1990.PubMedCrossRefGoogle Scholar
  80. 80.
    Delone P, Trollinger R, Fox N, et al.: Noncompliance in renal transplant recipients. Methods for recognition and intervention. Transplant Proc 21: 3982–3984, 1989.PubMedGoogle Scholar
  81. 81.
    Artero M, Biava C, Amend W, et al.: Recurrent focal glomerulosclerosis. Natural history and response to therapy. Am J Med 92: 375–383, 1992.PubMedCrossRefGoogle Scholar
  82. 82.
    Berger J, Yaneva H, Nabarva B, et al.: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7: 232–241, 1975.PubMedCrossRefGoogle Scholar
  83. 83.
    Goss JA, Cole BR, Jendrisak MD, et al.: Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. Transplantation 52: 805–810, 1991.PubMedCrossRefGoogle Scholar
  84. 84.
    Matthew TH: Recurrence of disease following renal transplantation. Am J Kidney Dis 12: 85–96, 1988.Google Scholar
  85. 85.
    McLean RH, Geiger H, Burke B, et al.: Recurrence of membranoproliferative GN following kidney transplantation. Am J Med 60: 60–65, 1976.PubMedCrossRefGoogle Scholar
  86. 86.
    Perez R, Matas AJ, Gillingham KJ, et al.: Lessons learned and future hopes: Three thousand renal transplants at the University of Minnesota. In: PI Terasaki, ed, Clinical Transplants 1990. UCLA Tissue Typing Laboratory, Los Angeles, 1991.Google Scholar
  87. 87.
    Ingulli E, Tejani A: Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis post-transplantation in 42 allografts-a single center experience. Transplantation 51: 401–405, 1991.PubMedCrossRefGoogle Scholar
  88. 88.
    Dantal J, Bigot E, Bogers W, et al.: Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 714, 1994.CrossRefGoogle Scholar
  89. 89.
    Cochat P, Kassir A, Colon S, et al.: Recurrent nephrotic syndrome after transplantation: early treatment with plasma pheresis and cyclophosphamide. Pediatr Nephrol 7: 50–54, 1993.PubMedCrossRefGoogle Scholar
  90. 90.
    Schwartz A, Krause PH, Offerman G, et al.: Recurrent and de novo renal disease after kidney transplantation. Am J Kidney Dis 17: 524–531, 1991.Google Scholar
  91. 91.
    Steinmuller DR, Stilmont M, Idelson B, et al.: De novo development of membranous nephropathy in cadaveric renal allografts. Clin Nephrol 9: 210–218, 1978.PubMedGoogle Scholar
  92. 92.
    The United States Renal Data Systems: 1993 Annual Report Counts of Renal Transplants by Primary Disease Causing ESRD. F8. National Institutes of Health, Bethesda, MD, March 1993.Google Scholar
  93. 93.
    Okiye S, Engen D, Sterioff S, et al.: Primary and secondary renal transplantation in diabetes. JAMA 249: 492–495, 1983.PubMedCrossRefGoogle Scholar
  94. 94.
    Haber W, Hoffken B, Freiling U, Ritz E: Professional training for the blind diabetic with nephropathy. Diabetic Nephropathy 4: 88–92, 1985.Google Scholar
  95. 95.
    Lemmers MJ, Barry JM: Major role for arterial disease in morbidity and mortality after kidney transplantation in diabetes. Diabetes Care 14: 295–301, 1991.PubMedCrossRefGoogle Scholar
  96. 96.
    Kennedy WR, Navarro X, Goetz F, et al.: The effects of pancreas transplantation on diabetic neuropathy. N Engl J Med 322: 1031–1037, 1990.PubMedCrossRefGoogle Scholar
  97. 97.
    Nathan DM, Fogel H, Xiorman D, et al.: Long term metabolic and quality of life results with pancreatic renal transplantation. Transplantation 52: 85–91, 1991.PubMedCrossRefGoogle Scholar
  98. 98.
    Mamdani B: Recovery of prolonged renal failure in patients with accelerated hypertension. N Engl J Med 291: 1343–1344, 1974.PubMedCrossRefGoogle Scholar
  99. 99.
    Garcia’ LL, Agüeru AE, Cavalli J, et al.: Kidney transplantation: Absolute and relative psychological contraindications. Transplant Proc 23: 1344–1345, 1991.Google Scholar
  100. 100.
    Wolcott D, Norquist G: Psychiatric aspects of kidney transplantation. In: G Darovitch, ed, Handbook of Kidney Transplantation. Little, Brown, Boston, pp 339–355, 1992.Google Scholar
  101. 101.
    Hunt J: Pretransplant evaluation and outcome. Semin Nephrol 12:227–223, 1992.Google Scholar
  102. 102.
    Eshbach J, Egrie JC, Downing MR, et al.: Correction of anemia of ESRD with recombinant human erythropoietin. N Engl J Med 316: 73–78, 1987.CrossRefGoogle Scholar
  103. 103.
    Ward HJ: Implications of recombinant erythropoietin therapy for renal transplantation. Am J Nephrol 10 (Suppl 2): 44–52, 1990.PubMedCrossRefGoogle Scholar
  104. 104.
    Kerman R, Flechner SM, Van Buren C, et al.: Investigation of HIV serology in a renal transplant population. Transplantation 43: 241–248, 1987.CrossRefGoogle Scholar
  105. 105.
    Rubin RH: Infection in the organ transplant patient. In: RH Rubin, LS Young, eds, Clinical Approach to Infection in the Compromised Host,3rd ed. Plenum, New York, in press.Google Scholar
  106. 106.
    Kerman R: Immune monitoring considerations in transplantation. In: MW Flye, ed, Principles of Organ Transplantation. WB Saunders, Philadelphia, pp 135–154, 1989.Google Scholar
  107. 107.
    Aldridge KE: Methicillin resistent staph aureus. Clinical and laboratory features. Infect Control 6: 461–465, 1985.PubMedGoogle Scholar
  108. 108.
    Catalona WJ, Smith DS, Ratliff T, et al.: Measurement of prostate specific antigen in serum as screening test for prostate cancer. N Engl J Med 324: 1156–1161, 1991.PubMedCrossRefGoogle Scholar
  109. 109.
    Weinrauch LA, D’Elia JA, Healy RW, et al.: Asymptomatic coronary artery disease in diabetic patients before renal transplantation. Relationship of findings to postoperative survival. Ann Intern Med 88: 346–348, 1978.PubMedCrossRefGoogle Scholar
  110. 110.
    Fischel RJ, Payne WD, Gillingham KJ, et al.: Long term outlook for renal transplant recipients with one year function. Transplantation 51: 118–122, 1992.CrossRefGoogle Scholar
  111. 111.
    American College of Physicians Health and Public Policy Committee: Efficacy of exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 113: 703–704, 1990.CrossRefGoogle Scholar
  112. 112.
    Holley JL, Fenton RA, Arthur RS: Thallium stress testing does not predict cardiovascular risk in diabetic patients with ESRD undergoing cadaver renal transplantation. Am J Med 90: 563–570, 1991.PubMedGoogle Scholar
  113. 113.
    Marwick TH, Steinmuller DR, Underwood DA, et al.: Ineffectiveness of dipyridamole thallium imaging as a screening technique for coronary artery disease in patients with ESRD. Transplantation 49: 100–102, 1989.CrossRefGoogle Scholar
  114. 114.
    Braun WE, Phillips DF, Vidt D, et al.: Coronary artery disease in 100 diabetics with ESRD. Transplant Proc 16: 603607, 1984.Google Scholar
  115. 115.
    Lorber MI, Van Buren CT, Flechner SM, et al.: Pretransplant coronary artery angiography for diabetic renal transplant recipients. Transplant Proc 19: 1539–1541, 1987.PubMedGoogle Scholar
  116. 116.
    Manske C, Thomas W, Wang Y: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44: 617–621, 1993.PubMedCrossRefGoogle Scholar
  117. 117.
    Manske C, Wang Y, Wilson RF, et al.: Coronary revascularization in insulin dependent diabetics with chronic renal failure. Lancet 340: 998–1002, 1992.PubMedCrossRefGoogle Scholar
  118. 118.
    Bissada NK: Incidence of vesical neck contracture complicating prostatic resection in hemodialysis patients. J Urol 117: 192–193, 1977.PubMedGoogle Scholar
  119. 119.
    Kogan S, Levitt S: Bladder evaluation in patients before undiversion in previously diverted urinary tracts.Google Scholar
  120. 120.
    Flechner SM, Conley SB, Brewer E, et al.: Intermittent clean catheterization. An alternative to diversion in continent transplant recipients. J Urol 130: 878–881, 1983.PubMedGoogle Scholar
  121. 121.
    Nguyen DH, Reinberg Y, Gonzalez R, et al.: Outcome of renal transplantation after urinary diversion and enterocytoplasty. J Urol 144: 1349–1351, 1990.PubMedGoogle Scholar
  122. 122.
    Thomalla JV, Mitchell M, Leapman S, et al.: Renal transplantation into the reconstructed bladder. J Urol 141: 265268, 1989.Google Scholar
  123. 123.
    Hatch DA, Belitsky P, Barry JM, et al.: Fate of renal allografts transplanted in patients with urinary diversion. Transplantation 56: 838–842, 1993.PubMedCrossRefGoogle Scholar
  124. 124.
    Fryd D, Sutherland D, Simmons R, et al.: Results of a prospective randomized study on the effect of splenectomy vs no splenectomy in renal transplantation. Transplant Proc 13: 4856, 1981.Google Scholar
  125. 125.
    Alexander JW, First M, Majeski J, et al.: The late adverse effect of splenectomy on patient survival following cadaver renal transplantation. Transplantation 37: 467–470, 1984.PubMedCrossRefGoogle Scholar
  126. 126.
    Alexandre EP, Squifflet JP, DeBruyere M, et al.: Splenectomy as a prerequisite for successful ABO incompatible renal transplantation. Transplant Proc 17: 138–140, 1985.Google Scholar
  127. 127.
    Owens MC, Passaro E, Wilson SE, et al.: Treatment of peptic ulcer disease in the renal transplant patient. Ann Surg 186: 19–21, 1979.Google Scholar
  128. 128.
    Stuart FP, Reckard C, Schulak J, et al.: Gastroduodenal complications in kidney transplant recipients. Ann Surg 194: 339345, 1981.Google Scholar
  129. 129.
    Klompmaker IJ, Sloof MJ, de Brnijn, et al.: Prophylaxis with ranitidine against peptic ulcer disease after liver transplantation. Transplant Int 1: 209–212, 1988.CrossRefGoogle Scholar
  130. 130.
    Jarowenko MV, Flechner SM, Van Buren C, et al.: Ranitidine, cimetidine, and the transplant kidney. Transplantation 42: 311–312, 1986.PubMedCrossRefGoogle Scholar
  131. 131.
    Lorber M, Van Buren CT, Flechner SM, et al.: Hepatobiliary complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation 43: 35–40, 1987.PubMedCrossRefGoogle Scholar
  132. 132.
    An analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med 324: 1073–1078, 1991.Google Scholar
  133. 133.
    Church IM, Fazio V, Braun WE, et al.: Perforation of the colon in renal homograft recipients. Ann Surg 203: 69–74, 1986.PubMedCrossRefGoogle Scholar
  134. 134.
    Guice K, Ratazzi L, Marchioro T: Colon perforation in renal transplant recipients. Am J Surg 138: 43–48, 1979.PubMedCrossRefGoogle Scholar
  135. 135.
    Ramos EL, Kasiske BL, Alexander SR, et al.: The evaluation of candidates for renal transplantation. Current practice of U.S. transplant centers. Transplantation 57: 490–497, 1994.PubMedGoogle Scholar
  136. 136.
    Opelz G, Terasaki PI: Improvement in kidney graft survival with increased numbers of blood transfusions. N Engl J Med 299: 799–803, 1978.PubMedCrossRefGoogle Scholar
  137. 137.
    Singal DP, Joseph S, Szewczuk M: Possible mechanisms of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man. Transplant Proc 14: 316–318, 1982.PubMedGoogle Scholar
  138. 138.
    Fagnilli L, Singal O: Blood transfusions may induce anti-T cell receptor antibiotics in renal patients. Transplant Proc 14: 319–322, 1982.PubMedGoogle Scholar
  139. 139.
    Groth C: There is no need to give blood transfusions for renal transplantation in the cyclosporine era. Transplant Proc 19: 153–154, 1987.PubMedGoogle Scholar
  140. 140.
    Scornik JC, Ireland JE, Howard RI, et al.: Assessment of the risk for broad sensitization by blood transfusions. Transplantation 37: 249–253, 1984.PubMedCrossRefGoogle Scholar
  141. 141.
    Ahmed Z, Terasaki PI: Effects of transfusions. In: Clinical Transplants 1992. UCLA Tissue Typing Laboratory, Los Angeles, pp 305–312, 1992.Google Scholar
  142. 142.
    Flechner SM, Kerman RH, Van Buren CT, et al.: The use of cyclosporine in living related renal transplantation. Transplantation 38: 685–690, 1984.PubMedCrossRefGoogle Scholar
  143. 143.
    Cheigh JS, Suthanthrinan M, Fotino M, et al.: Minimal sensitization and excellent renal allograft outcome following DST with short course of cyclosporine. Transplantation 51: 378381, 1991.Google Scholar
  144. 144.
    Cecka MJ, Terasaki PI: The UNOS Scientific Transplant Registry. In: Clinical Transplants 1993. UCLA Tissue Typing Laboratory, Los Angeles, pp 1–18, 1994.Google Scholar
  145. 145.
    Opelz G, Mytilneos J, Scherer S, et al.: Survival of DNA HLA-Dr typed and matched cadaver kidney transplants. Lancet 338: 461–463, 1991.PubMedCrossRefGoogle Scholar
  146. 146.
    Cochrum KC, Salvatierra O, Belzer F: Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg 1801: 617–622, 1974.CrossRefGoogle Scholar
  147. 147.
    Murray J, Merrill J, Harrison J: Renal homotransplantation in identical twins. Surg Forum 6: 432–435, 1955.Google Scholar
  148. 148.
    Tilney NL: Renal transplantation between identical twins: a review. World J Surg 10: 381–388, 1986.PubMedCrossRefGoogle Scholar
  149. 149.
    Flechner SM, Kerman RH, Van Buren CT, et al.: Does cyclosporine improve the results of HLA-identical renal transplantation? Transplant Proc 19: 1485–1488, 1987.PubMedGoogle Scholar
  150. 150.
    Leivstad T, Albrechtsen D, Flatmark A, et al.: Renal transplants from HLA haploidentical living related donors. Transplantation 42: 35–38, 1986.CrossRefGoogle Scholar
  151. 151.
    Sommer BG, Ferguson RM: Mismatched living related renal transplantation. A prospective randomized study. Surgery 98: 269–275, 1985.Google Scholar
  152. 152.
    Cochrum KC, Hanes D, Potter D, et al.: Donor specific blood transfusions in HLA-D disparate one haplotype related allografts. Transplant Proc 11:1903–1907, 1979.Google Scholar
  153. 153.
    Salvatierra O, Vincenti F, Amend W, et al.: Four year experience with donor specific blood transfusions. Transplant Proc 15: 924–931, 1983.Google Scholar
  154. 154.
    Simmons RG: Long term reactions of renal recipients and donors. In: NB Levey, ed, Psychonephrology: Psychologic Problems in Kidney Failure and Their Treatment. Plenum Press, New York, pp 275–287, 1983.Google Scholar
  155. 155.
    Marshall J, Fellner C: Kidney donors revisited. Am J Psychiatry 134: 575–576, 1977.PubMedGoogle Scholar
  156. 156.
    Madsen V: Harrison (1957) Massachusetts Supreme Judicial Court Equity number 68651.Google Scholar
  157. 157.
    Santiago EA, Simmons R, Kjellstrand C, et al.: Life insurance prospective for the living kidney donor. Transplantation 14: 131–133, 1972.PubMedCrossRefGoogle Scholar
  158. 158.
    Spital A: Life insurance for kidney donors, an update. Trans-plantation 45: 819–822, 1988.Google Scholar
  159. 159.
    Merrill JP: Moral problems of artificial and transplanted organs. Ann Intern Med 61: 355–364, 1964.CrossRefGoogle Scholar
  160. 160.
    Leary F, DeWeerd J: Living donor nephrectomy. J Urol 109: 947–951, 1973.PubMedGoogle Scholar
  161. 161.
    Weiland D, Sutherland D, Chavers B, et al.: Information on 628 living related kidney donors at a single institution with long term follow up on 472 cases. Transplant Proc 16: 5–7, 1984.Google Scholar
  162. 162.
    Brenner B, Meger T, Hostetter T: Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307: 652–6659, 1982.PubMedCrossRefGoogle Scholar
  163. 163.
    Vincenti F, Amend W, Kaysen G, et al.: Long term renal function in kidney donors. Transplantation 36: 626–629, 1984.CrossRefGoogle Scholar
  164. 164.
    Dunn J, Nylander W, Ritchie R, et al.: Living related kidney donors. Ann Surg 203: 637–642, 1986.PubMedCrossRefGoogle Scholar
  165. 165.
    Robitaille P, Lortie L, Mongean J, et al.: Long term follow up of patients who underwent unilateral nephrectomy in childhood. Lancet 1: 1297–1299, 1985.PubMedCrossRefGoogle Scholar
  166. 166.
    Najarian JS, Chavers B, McHugh L, et al.: Twenty years or more of follow up of living kidney donors. Lancet 340: 807810, 1992.Google Scholar
  167. 167.
    Levery A, Hou S, Bash H: Sounding Board: Kidney transplantation from unrelated living donors. N Engl J Med 314: 914–916, 1986.CrossRefGoogle Scholar
  168. 168.
    Spital A: Unconventional living kidney donors-attitudes and use among transplant centers. Transplantation 48: 243245, 1989.Google Scholar
  169. 169.
    Kaufman D, Matas A, Arrazola L, et al.: Transplantation of kidneys from zero haplotype matched live donors and unrelated donors in the cyclosporine era. Transplant Proc 25: 1530–1532, 1993.PubMedGoogle Scholar
  170. 170.
    Hiraga S, Tanaka K, Watanabe J, et al.: Unrelated living donor renal transplantation. Transplant Proc 24: 1320–1322, 1992.PubMedGoogle Scholar
  171. 171.
    Pirsch J, D’Allessandro A, Sollinger H, et al.: Living unrelated renal transplantation at the University of Wisconsin. In: PI Terasaki, ed, Clinical Transplants 1990. UCLA Tissue Typing Laboratory, Los Angeles, 1991.Google Scholar
  172. 172.
    Wyner L, Novick AC, Streem S, et al.: Improved success of unliving related renal transplantation with cyclosporine. J Urol 149: 706–709, 1993.PubMedGoogle Scholar
  173. 173.
    Bart KJ, Macon E, Humphreys A: Increasing the supply of cadaveric kidneys for transplantation. Transplantation 31: 383–387, 1981.PubMedCrossRefGoogle Scholar
  174. 174.
    Kries H: Why living related donors should not be used whenever possible. Transplant Proc 17:1510–1514, 1985.Google Scholar
  175. 175.
    Council of the Transplantation Society: Commercialization in transplantation. The problems and some guidelines for practice. Lancet 2: 715–716, 1985.Google Scholar
  176. 176.
    Carpenter C, Ettenger R, Strom T: “Free market” approach to organ donation. N Engl J Med 310: 395–396, 1984.PubMedGoogle Scholar
  177. 177.
    World Health Organization: Guiding principles on human organ transplantation. Lancet 337: 1470–1471, 1991.CrossRefGoogle Scholar
  178. 178.
    Askari A, Novick A, Braun W, et al.: The older living related donor. Prognosis for the donor and recipient. J Urol 129:779780, 1980.Google Scholar
  179. 179.
    Buszta C, Steinmuller DR, Schreiber M, et al.: Pregnancy after donor nephrectomy. Transplantation 40: 651–654, 1985.PubMedCrossRefGoogle Scholar
  180. 180.
    Tolkoff-Rubin NE, Rubin RH: Clinical approach to viral and fungal infections in the renal transplant patient. Semin Nephrol 12: 364–375, 1992.PubMedGoogle Scholar
  181. 181.
    Flechner SM, Sandler CM, Houston GK, et al.: 100 living related kidney donor evaluations using digital subtraction angiography. Transplantation 40: 675–678, 1985.PubMedCrossRefGoogle Scholar
  182. 182.
    Spencer W, Streem S, Geisinger MA, et al.: Outcome angiographic evaluation of living renal donors. J Urol 140: 1364–1366, 1988.PubMedGoogle Scholar
  183. 183.
    Richmond, Va.: United network for organ sharing. UNOS Update 5: 9, 1989.Google Scholar
  184. 184.
    Darby JM, Stein K, Grenuik A, et al.: Approach to management of the heartbeating “brain dead” organ donor. JAMA 261: 2222–2226, 1989.PubMedCrossRefGoogle Scholar
  185. 185.
    Rubin RH, Jenkins RL, Shaw BW, et al.: The acquired immunodeficiency syndrome and transplantation. Transplantation 44: 1–4, 1987.PubMedCrossRefGoogle Scholar
  186. 186.
    Phillips MG, ed: Organ Procurement, Preservation, and Distribution in Transplantation. UNOS, Richmond, VA, 1991.Google Scholar
  187. 187.
    Pallis C: Brainstem death. The evolution of a concept. In: PJ Morris, ed, Kidney Transplantation. Principles and Practice. Grune and Stratton, London, pp 101–127, 1984.Google Scholar
  188. 188.
    Schwartz J, Baxter J, Bull D: Radionuclide cerebral imaging confirming brain death. JAMA 249: 246–247, 1983.PubMedCrossRefGoogle Scholar
  189. 189.
    Lucas BA, Vaughn WK, Spees EK, et al.: Identification of donor factors predisposing to high discard rates of cadaveric kidneys and increased graft loss within one year post transplant. Transplantation 43: 253–257, 1987.PubMedCrossRefGoogle Scholar
  190. 190.
    Kaplan C, Posternak B, Shah H, et al.: Age related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80: 227234, 1975.Google Scholar
  191. 191.
    Starzl TE, Hakala TR, Shaw BW, et al.: A flexible procedure for multiple cadaveric organ procurement. SGO 158: 223230, 1984.Google Scholar
  192. 192.
    Ploeg R: Kidney preservation with the UW and and EuroCollins solutions. Transplantation 49: 281–284, 1990.PubMedCrossRefGoogle Scholar
  193. 193.
    Southard JH, Van Gulik TM, Ametani MS, et al.: Important components of the UW solution. Transplantation 49: 251–257, 1990.PubMedCrossRefGoogle Scholar
  194. 194.
    Alexander JW: Expanded Donor Criteria: Background and Suggestions for Kidney Donation. Report of the UNOS Ad Hoc Donations Committee, Richmond, VA, 1992.Google Scholar
  195. 195.
    Yuge J, Cecka JM: Pediatric recipients and donors. In: PI Terasaki, ed, Clinical Transplants 1990. UCLA Tissue Typing Laboratory, Los Angeles, 1991.Google Scholar
  196. 196.
    Alexander JW, Vaughn WK: Use of “marginal donors” for organ transplantation. Transplantation 51: 135, 1991.PubMedCrossRefGoogle Scholar
  197. 197.
    Alexander JW, Bennett LE, Breen TJ: Effect of donor outcome of kidney transplantation: 2 year analysis of transplants reported to the UNOS Registry. Transplantation 57: 871–876, 1994.PubMedCrossRefGoogle Scholar
  198. 198.
    Preuschot L, Lobo C, Offerman G: Role of cold ischemic time and vascular rejection from elderly donors. Transplant Proc 23: 1300–1303, 1991.Google Scholar
  199. 199.
    Rosenthal JT, Danovitch GM, Wilkinson A, et al.: The high cost of delayed graft function in cadaver renal transplantation. Transplantation 51: 1115–1120, 1991.PubMedCrossRefGoogle Scholar
  200. 200.
    Shackleton CR, Ettinger SL, McLoughlin MG, et al.: Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation 49: 641–645, 1990.PubMedCrossRefGoogle Scholar
  201. 201.
    Wakabayashi H, Miyauchi A, Karasawa Y, et al.: Effect of warm ischemia on reperfusion injury on inducing major histocompatibility complex antigens. Transplant Proc 25: 32053207, 1993.Google Scholar
  202. 202.
    Kuhan BD, Mickey R, Flechner SM, et al.: Multivariate analysis of risk factors impacting on immediate and eventual graft survival in cyclosporine treated recipients. Transplantation 43: 65–71, 1987.CrossRefGoogle Scholar
  203. 203.
    Brown MW, Akyol AM, Bradley JA, et al.: Transplantation of cadaver kidneys from pediatric donors. Clin Transplant 2: 87–90, 1988.Google Scholar
  204. 204.
    Creagh TA, McLean PA, Spencer S, et al.: Transplantation of kidneys from pediatric cadaver donors to adult recipients. J Urol 146: 951–952, 1991.PubMedGoogle Scholar
  205. 205.
    Nghiem DD: En bloc transplantation of kidneys from donors weighing less than 15 kg into adult recipients. J Urol 145: 1416, 1991.Google Scholar
  206. 206.
    Darras F, Jordan M, Shapiro R, et al.: Transplantation of pediatric en bloc kidneys with FK506 immunosuppression. Transplant Proc 23: 3089–3090, 1991.PubMedGoogle Scholar
  207. 207.
    Harmon WE, Alexander SR, Tejani A, et al.: The effect of donor age on graft survival in pediatric cadaver renal transplant recipients. Transplantation 54: 232–236, 1992.PubMedCrossRefGoogle Scholar
  208. 208.
    Rosenthal JT, Miserantino DP, Mendez R, et al.: Extending the criteria for cadaver kidney donors. Transplant Proc 22: 338–340, 1990.PubMedGoogle Scholar
  209. 209.
    Spees EK, et al.: Successful use of cadaver kidneys from diabetic donors for transplantation. Transplant Proc 22: 378379, 1990.Google Scholar
  210. 210.
    Abouna GM, Adnani MS, Kumar MS, et al.: Reversal of diabetic glomerulopathy in human cadaveric kidneys after transplantation into nondiabetic recipients. Lancet 1: 62 2624, 1986.Google Scholar
  211. 211.
    Catelao AM, Grino JM, Gonzalez C, et al.: Long term renal function of kidneys transplanted from non-heart beating donors. Transplant Proc 23: 2584–2586, 1991.Google Scholar
  212. 212.
    Younger SJ, Arnold RM: Ethical, psychosocial, and public policy implications of procuring organs from non-heart beating donors. JAMA 269: 2769–2772, 1993.CrossRefGoogle Scholar
  213. 213.
    Kootstra G, Wijner R, van Hoof JP, et al.: Twenty percent more kidneys through a non-heart beating program. Transplant Proc 23: 910–912, 1991.PubMedGoogle Scholar
  214. 214.
    Park MS, Barbetti AA, Geer LI, et al.: HLA epitopes depicted by serology. In: PI Terasaki, ed, Clinical Transplants 1990. UCLA Tissue Typing Laboratory, Los Angeles, pp 515, 1991.Google Scholar
  215. 215.
    Uryu N, Maeda M, Ota M, et al.: A simple and rapid method of HLA DrB and DQB typing by digestion of PCR amplified DNA with allele specific restriction endonucleases. Tissue Antigens 35: 20–31, 1990.PubMedCrossRefGoogle Scholar
  216. 216.
    Bidwell J: DNA-RFLP analysis and genotyping of HLA-Dr and DQ antigens. Immunol Today 9: 18–23, 1988.PubMedCrossRefGoogle Scholar
  217. 217.
    Clay TM, Bidwell JL, Howard MR, et al.: PCR fingerprinting for selection of HLA matched unrelated marrow donors. Lancet 337: 1049–1052, 1991.PubMedCrossRefGoogle Scholar
  218. 218.
    UNOS Policy 3.3.1, Richmond, VA. United Network for Organ Sharing, 1990.Google Scholar
  219. 219.
    Terasaki PI, Takemoto S, Mickey MR: A report on 128 six antigen matched cadaver kidney transplants. Clin Transplant 3: 301–305, 1989.Google Scholar
  220. 220.
    Takemoto S, Terasaki PI, Cecka JM, et al.: The UNOS Scientific Renal Transplant Registry. Survival of nationally shared HLA matched kidney transplants from cadaveric donors. N Engl J Med 327: 834–839, 1992.PubMedCrossRefGoogle Scholar
  221. 221.
    Takemoto, Carnahan E, Terasaki PI: Report on 604 six antigen matched transplants. In: PI Terasaki, ed, Clinical Transplants 1990. UCLA Tissue Typing Laboratory, Los Angeles, pp 485–495, 1991.Google Scholar
  222. 222.
    Terasaki PI, Cecka JM, Gjertson DW, et al.: A ten year prediction for kidney transplant survival. In: PI Terasaki, ed, Clinical Transplants 1992. UCLA Tissue Typing Laboratory, Los Angeles, pp 501, 1993.Google Scholar
  223. 223.
    Gjertson DW, Terasaki PI: The large center variation in half-lives of kidney transplants. Transplantation 52: 357–361, 1992.CrossRefGoogle Scholar
  224. 224.
    Matas AJ, Frey DJ, Gillingham KJ, et al.: The impact of HLA matching on graft survival and on sensitization after a failed transplant. Evidence that failure of poorly matched renal transplants does not result in increased sensitization. Transplantation 50: 599–605, 1990.PubMedCrossRefGoogle Scholar
  225. 225.
    Cicciarelli J, Terasaki PI, Mickey R: The effect of zero HLA class I and II mismatching in CSA treated kidney patients. Transplantation 43: 636–640, 1987.PubMedCrossRefGoogle Scholar
  226. 226.
    Gilks W, Bradley B, Gore S, et al.: Substantial benefits of tissue matching in renal transplantation. Transplantation 43: 669–674, 1987.PubMedCrossRefGoogle Scholar
  227. 227.
    Mytillneos J, Scherer S, Dunckley H, et al.: DNA HLA-Dr typing results of 4000 kidney transplants. Transplantation 55: 778–782, 1993.CrossRefGoogle Scholar
  228. 228.
    Ichikawa Y, Hashimoto M, Nojima M, et al.: The significant effect of HLA-DrBI matching on long term kidney graft outcome. Transplantation 56: 1368–1371, 1993.PubMedCrossRefGoogle Scholar
  229. 229.
    Takemoto S, Terasaki PI, Gjertson DW, et al.: Equitable allocation of HLA compatible kidneys for local pools and for minorities. N Engl J Med,in press.Google Scholar
  230. 230.
    Najarian JS, Gillingham KJ, Sutherland DR, et al.: The impact of the quality of initial graft function in cadaver kidney transplantation. Transplantation 57: 812–815, 1994.PubMedCrossRefGoogle Scholar
  231. 231.
    Gaston RS, Ayres JD, Dooley LG, et al.: Racial equity in renal transplantation: the disparate impact of HLA based allocation. JAMA 270: 1352–1356, 1993.PubMedCrossRefGoogle Scholar
  232. 232.
    Foca N, Reed E, Rohowsky C, et al.: Influence of race on the predictability of MLC identity by HLA-Dr matching. Transplantation 35: 35–39, 1983.CrossRefGoogle Scholar
  233. 233.
    Milford E, Ratner L, Yunis E: Will transplant immunogenetics improve graft survival in blacks? Racial variability in the accuracy of tissue typing for organ donation. Transplant Proc 19: 30–32, 1987.PubMedGoogle Scholar
  234. 234.
    Lazda VA: The impact of HLA frequency differences in races in the access to optimally HLA matched cadaver renal transplants. Transplantation 53: 352–357, 1992.PubMedCrossRefGoogle Scholar
  235. 235.
    Barger B, Shroyer TW, Hudson SL, et al.: The impact of the UNOS mandatory sharing policy on recipients of the black and white races-experience at a single center. Transplantation 58: 770–774, 1992.CrossRefGoogle Scholar
  236. 236.
    Lazda VA: An evaluation of a local variance of the UNOS point system on the distribution of cadaver kidneys to waiting minority recipients. Transplant Proc 23: 901–902, 1991.PubMedGoogle Scholar
  237. 237.
    Rubin RH: Impact of CMV infection on organ transplant recipients. Rev Infect Dis 12: S754 - S766, 1990.PubMedCrossRefGoogle Scholar
  238. 238.
    Chou S: Acquisition of donor strains of CMV by renal transplant recipients. N Engl J Med 314: 1418–1423, 1986.PubMedCrossRefGoogle Scholar
  239. 239.
    Grundy JE, Super M, Lui S, et al.: The source of CMV infection in sero positive renal allograft recipients is frequently the donor kidney. Lancet 16: 132–135, 1988.CrossRefGoogle Scholar
  240. 240.
    Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al.: Symptomatic CMV disease in the sero positive renal transplant recipient treated with OKT3. Transplantation 53: 68–72, 1992.PubMedCrossRefGoogle Scholar
  241. 241.
    Snydman DR, Werner BG, Heinze B, et al.: Use of CMV immune globulin to prevent CMV disease in renal transplant patients. N Engl J Med 317: 1049–1054, 1987.PubMedCrossRefGoogle Scholar
  242. 242.
    Balfour H, Chace BA, Stapleton IT, et al.: A randomized placebo controlled trial of oral acyclovir for the prevention of CMV disease in recipients of renal allografts. N Engl J Med 320: 1381–1387, 1989.PubMedCrossRefGoogle Scholar
  243. 243.
    Dunn DL, Gillingham KJ, Kramer MA, et al.: A prospective, randomized study of acyclovir vs ganciclovir plus human immune globulin prophylaxis of CMV infection after solid organ transplantation. Transplantation 57: 876–884, 1994.PubMedCrossRefGoogle Scholar
  244. 244.
    Hibberd PL, Tolkoff-Rubin NE, Doran M, et al.: Preemptive therapy with ganciclovir during OKT3 administration. Proc ASTS 11: 125, 1992.Google Scholar
  245. 245.
    Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, et al.: Quantitative oropharyngeal EBV virus shedding in renal and cardiac transplant recipients. J Infect Dis 166: 986–994, 1992.PubMedCrossRefGoogle Scholar
  246. 246.
    Denning D, Weiss LM, Flechner SM: Transmission of EBV by a transplanted kidney with activation by OKT3 antibody. Transplantation 48: 141–144, 1989.PubMedCrossRefGoogle Scholar
  247. 247.
    Stephanian E, Gruber SA, Dunn DL, et al.: Post-transplant lymphoproliferative disorders. Transplant Rev 5: 120–129, 1991.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Stuart M. Flechner
    • 1
  1. 1.Department of Urology/A100 Section of Renal Transplantation ClevelandClinic FoundationClevelandUSA

Personalised recommendations